QR-Code

A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates

As new SARS-CoV-2 variants continue to emerge and impact communities worldwide, next-generation vaccines that enhance protective mucosal immunity may have a significant impact on productive infection and transmission. We have developed recombinant non-replicating adenovirus serotype 5 (rAd5) vaccine...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Sarah N. Tedjakusuma, Colin A. Lester, Elena D. Neuhaus, Emery G. Dora, Samanta Gutierrez, Molly R. Braun, Sean N. Tucker, Becca A. Flitter
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2024-01-01
Schriftenreihe:Vaccines
Schlagworte:
adenovirus vaccines
immunity
mucosal
SARS-CoV-2
immunoglobulin A
Online-Zugang:https://www.mdpi.com/2076-393X/12/2/132
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge